scholarly journals Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein

BMC Cancer ◽  
2006 ◽  
Vol 6 (1) ◽  
Author(s):  
Emiliano Pavoni ◽  
Michela Flego ◽  
Maria Luisa Dupuis ◽  
Stefano Barca ◽  
Fiorella Petronzelli ◽  
...  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Zahra Shadman ◽  
Safar Farajnia ◽  
Mohammad Pazhang ◽  
Mohammadreza Tohidkia ◽  
Leila Rahbarnia ◽  
...  

Abstract Background Pseudomonas aeruginosa is the leading cause of nosocomial infections, especially in people with a compromised immune system. Targeting virulence factors by neutralizing antibodies is a novel paradigm for the treatment of antibiotic-resistant pseudomonas infections. In this respect, exotoxin A is one of the most potent virulence factors in P. aeruginosa. The present study was carried out to identify a novel human scFv antibody against the P. aeruginosa exotoxin A domain I (ExoA-DI) from a human scFv phage library. Methods The recombinant ExoA-DI of P. aeruginosa was expressed in E. coli, purified by Ni-NTA column, and used for screening of human antibody phage library. A novel screening procedure was conducted to prevent the elimination of rare specific clones. The phage clone with high reactivity was evaluated by ELISA and western blot. Results Based on the results of polyclonal phage ELISA, the fifth round of biopanning leads to the isolation of several ExoA-DI reactive clones. One positive clone with high affinity was selected by monoclonal phage ELISA and used for antibody expression. The purified scFv showed high reactivity with the recombinant domain I and full-length native exotoxin A. Conclusions The purified anti-exotoxin A scFv displayed high specificity against exotoxin A. The human scFv identified in this study could be the groundwork for developing a novel therapeutic agent to control P. aeruginosa infections.


Toxicon ◽  
2019 ◽  
Vol 171 ◽  
pp. 78-85
Author(s):  
Fatemeh Kazemi-Lomedasht ◽  
Montarop Yamabhai ◽  
Jean-Marc Sabatier ◽  
Mahdi Behdani ◽  
Mohammad Reza Zareinejad ◽  
...  

1997 ◽  
Vol 21 (2) ◽  
pp. 100
Author(s):  
H.L. Zhang ◽  
I.W. Khor ◽  
D.A. Evans ◽  
S.L. Kaattari
Keyword(s):  

2001 ◽  
Vol 50 (2) ◽  
pp. 93-101 ◽  
Author(s):  
Cindy Wong ◽  
Robert Waibel ◽  
Michael Sheets ◽  
Jean-Pierre Mach ◽  
Ricarda Finnern

2006 ◽  
Vol 44 (2) ◽  
pp. 65 ◽  
Author(s):  
Guanxin Shen ◽  
Limin Cao ◽  
Yinchang Zhu ◽  
Weiyu Wang ◽  
Xiaorong Zhao ◽  
...  

Bioengineered ◽  
2016 ◽  
Vol 8 (5) ◽  
pp. 501-510 ◽  
Author(s):  
Hamid Nickho ◽  
Vahid Younesi ◽  
Leili Aghebati-Maleki ◽  
Morteza Motallebnezhad ◽  
Jafar Majidi Zolbanin ◽  
...  

2018 ◽  
Vol 243 (7) ◽  
pp. 621-626 ◽  
Author(s):  
Jiraprapa Wipasa ◽  
Romanee Chaiwarith ◽  
Kriangkrai Chawansuntati ◽  
Jutarat Praparattanapan ◽  
Kritsadee Rattanathammethee ◽  
...  

A major characteristic of immunodeficiency associated with life-threatening intracellular infection in adults is the presence of anti-interferon-γ antibodies. Although little is known about the mechanism underlying this syndrome, it is believed that the antibodies inhibit the activity of downstream signaling pathway of interferon-γ. In this study, the characteristics of these antibodies in patients who presented, or have a history of, intracellular infection and were positive to anti-interferon-γ antibodies were investigated. The antibodies exhibited mainly the IgG1 and the IgG4 subtypes and recognized the C-terminal of the interferon-γ linear epitope containing the KRKR motif, which is required for the biological activity of interferon-γ. The antibodies bound to recombinant interferon-γ with significantly lower avidity than antibodies to a recall antigen, tetanus toxoid, suggesting that the antibodies might have not undergone affinity maturation. The data from this study may provide fundamental information to better understand the properties of anti-interferon-γ antibodies, which can be useful for future studies. Impact statement An increase in the number of immunodeficient patients related to autoantibodies to interferon (IFN)-γ has been observed particularly in East Asian adults. These patients are often presented with opportunistic infections caused by intracellular pathogens, including non-tuberculous mycobacteria (NTM), Cryptococcus neoformans, Penicillium marneffei (now called Talaromyces marneffei), and non-typhoidal Salmonella spp. The mortality rate for this syndrome is relatively high with 32% patients dying at the median time of 25 months after diagnosis. Characterization of these autoantibodies may promote better understanding of the syndrome, an emerging health problem affecting East Asia populations and impeding their welfare and economic development.


Sign in / Sign up

Export Citation Format

Share Document